
Iowa Academy of Otolaryngology Annual Meeting
Registration |
---|
If you have questions, please contact Michelle Decker at [email protected] or 515-421-4778. |
Target Audience
Open to the members of the Iowa Academy of Otolaryngology.
Purpose
Remaining current in surgical and routine procedures in the area of otolaryngology is critical in ensuring quality of care and desired patient outcomes. This activity is designed to increase the knowledge of learners in multiple surgical and routine procedure processes.
Learning Objectives
- Discusses challenges that have arisen during sinonasal procedures.
- Explore innovative approaches from benign to malignant to inflammatory.
- Explain complications that may arise during sinus surgery.
- Explain complications that may arise during endoscopic pituitary surgery.
- Discuss the most current information related to maxillary sinus tumor treatment.
- Discuss the latest information on treating facial trauma.
- Explore treatment options for neutrophilic inflammation in chronic rhinosinusitis.
- Examine the latest information related to office-based sinus procedures.
Agenda
7 am | Registration and Breakfast |
8 am | Challenging Sinonasal Cases and Innovative Approaches from Benign to Malignant to Inflammatory Eugene H. Chang, MD, FACS |
10 am | Break |
10:15 am | Complication of Sinus Surgery and Endoscopic Pituitary Surgery Scott M. Graham, MBBS |
11:15 am | Break |
11:30 am | Maxillary Sinus Tumors Rodrigo Bayon, MD |
12 pm | Facial Trauma Scott Owen, MD |
12:30 pm | Lunch |
1:15 pm | Neurtrophilic Inflammation in Chronic Rhinosinusitis Jarrett Walsh, MD |
1:45 pm | Adjourn |
DISCLOSURES
Relevant to the content of this educational activity, the following individual(s) have no conflict of interests with commercial interest companies to disclose.
- Rodrigo Bayon, MD, Speaker
- Michelle Dekker, CMP, Planning Committee Member
- Autumn McGill, Planning Committee Member
- Scott Owen, MD, Speaker
- Jarrett Walsh, MD, Speaker
Relevant to the content of this educational activity, the following individual(s) have a conflict of interest with commercial interest companies to disclose.
- Eugene H. Chang, MD, FACS, Speaker - Consultant for Olympus and receives grant/research support from the NIH and Acclarent
- Scott M. Graham, MBBS, Speaker - No relationships with commercial interest companies but will discuss the off-label use of intrathecal fluorescein
Continuing Education Credit
MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Iowa Academy of Otolaryngology. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 4.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 4.5 continuing education contact hour(s). No partial credit awarded.
- Other Health Professional: This live activity is designated for 4.5 AMA PRA Category 1 Credit(s)TM.
Educational Grants
No commercial interest company provided financial support for this continuing education activity.
Disclosure
Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. They will also disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas. The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 4.50 AMA PRA Category 1 Credits™
- 4.50 AOA Category 2A
- 4.50 CE Contact Hour(s)
- 4.50 IBON
Price
There is no cost to attend. Click here to register.
If you have questions, please contact Michelle Decker at [email protected] or 515-421-4778.